Ad
ABMD Short Information ABIOMED Inc.
home / stock / abmd / abmd short
Short Information | ABIOMED Inc. (NASDAQ:ABMD)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 2,837,769 |
| Total Actual Volume | 43,646,424 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 141,888 |
| Average Short Percentage | 7.30% |
Is there a ABMD Short Squeeze or Breakout about to happen?
See the ABMD Short Analysis for free Sign up or Login
Powered by Squeeze Report
ABMD Twenty Trading Day's Volume to Short Volume Chart
ABMD Twenty Trading Day Price Chart
ABMD Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 12-21-2022 | $380.78 | $381.02 | $381.28 | $380.51 | 20,612,257 | 1,339,637 | 6.5% |
| 12-20-2022 | $381.21 | $380.79 | $381.3 | $380.5 | 2,401,328 | 265,260 | 11.05% |
| 12-19-2022 | $381.25 | $381.3 | $381.69 | $381.18 | 1,365,881 | 90,687 | 6.64% |
| 12-16-2022 | $380.75 | $381 | $381.45 | $380.75 | 1,538,419 | 100,307 | 6.52% |
| 12-15-2022 | $380.12 | $380.16 | $380.5 | $380.11 | 834,551 | 109,998 | 13.18% |
| 12-14-2022 | $380.45 | $380.11 | $380.59 | $380.1 | 1,415,274 | 44,883 | 3.17% |
| 12-13-2022 | $380.29 | $380.3 | $381.03 | $380.1 | 4,565,692 | 156,634 | 3.43% |
| 12-12-2022 | $380.99 | $380.01 | $380.99 | $379.98 | 1,317,734 | 89,544 | 6.8% |
| 12-09-2022 | $380.33 | $380.75 | $381.025 | $380.25 | 990,056 | 33,941 | 3.43% |
| 12-08-2022 | $381.8 | $380.75 | $381.8 | $380.25 | 1,506,892 | 66,051 | 4.38% |
| 12-07-2022 | $377.41 | $377.79 | $378.09 | $377.25 | 974,143 | 44,008 | 4.52% |
| 12-06-2022 | $378 | $377.95 | $378.19 | $376.97 | 672,274 | 61,479 | 9.14% |
| 12-05-2022 | $377.21 | $378.22 | $378.57 | $376.84 | 886,171 | 63,725 | 7.19% |
| 12-02-2022 | $376.8 | $377.2 | $378 | $376.55 | 704,751 | 36,200 | 5.14% |
| 12-01-2022 | $377.85 | $377.44 | $377.95 | $376.5608 | 643,990 | 54,668 | 8.49% |
| 11-30-2022 | $377.79 | $377.79 | $378.5 | $377.02 | 733,880 | 39,806 | 5.42% |
| 11-29-2022 | $377.58 | $377.33 | $377.83 | $377.3 | 592,032 | 48,388 | 8.17% |
| 11-28-2022 | $377.51 | $377.23 | $378.18 | $377.005 | 830,289 | 79,365 | 9.56% |
| 11-25-2022 | $377.36 | $378.08 | $378.285 | $377.01 | 258,929 | 35,259 | 13.62% |
| 11-23-2022 | $378 | $377.78 | $378.36 | $377.63 | 801,881 | 77,929 | 9.72% |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients have been enrolled in the trial. Amir Kaki, MD, director of mechanical circulatory support...
-
Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 PR Newswire NEW YORK , Dec. 19, 2022 /PRNewswire/ -- S&P MidCap 400 constituent...
-
Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed’s newest heart pump for patients experiencing right heart failure. All three patients have now been successfully weaned off Impella support and two have...